President Donald Trump’s latest health‑care initiative – a nationwide discount on the high‑cost drugs used in in‑vitro fertilisation (IVF) – has drawn unexpected applause from many who normally oppose his administration. After months of behind‑the‑scenes negotiations involving pharmaceutical companies, fertility clinics, and congressional committees, the White House announced that the...